Hopkinton Bans Synthetic Cannabinoid and Kratom Sales
The Hopkinton synthetic cannabinoid kratom ban prohibits local sales of these products starting July 30. This municipal action targets unregulated synthetic cannabinoids and kratom products sold outside the regulated cannabis system. It highlights the…
A South Jersey Man Sues CBD Kratom Stores Over Kratom Addiction
This article discusses kratom addiction liability and its opioid receptor activity, highlighting a South Jersey man's lawsuit against CBD Kratom stores. Kratom's addiction risks differ significantly from CBD, requiring careful clinical assessment.…
Missouri AG Sues CBD American Shaman Over Kratom Products – KFVS12
Missouri Attorney General sues CBD American Shaman over kratom products, raising important regulatory and patient safety issues. This lawsuit highlights the challenges in overseeing CBD and kratom sales. Patients and clinicians should be aware of the…
Missouri Attorney General Takes Legal Action Against American Shaman for Kratom Products
Missouri attorney general sues American Shaman over kratom products, emphasizing regulatory confusion impacting patient safety. The lawsuit highlights the need for clinicians to verify product contents. This case underscores distinct legal and…
Nonswallowed Kratom-Derived Products: Unlawful Dietary Supplements That Endanger Public Health.
Kratom regulatory safety is critical as non-oral kratom products bypass FDA oversight and violate dietary supplement laws. These unlawful formulations may endanger public health due to unknown safety profiles. Clinicians should be aware of these risks…
Cannabis Dispensary Owner Raises Alarm on 7-OH Product Safety
7-OH product safety concerns are rising as potent kratom-derived opioids enter unregulated markets. Cannabis dispensary owners urge local action to protect patients. Awareness of these risks is critical for clinical safety.